Dyslipidemia and Non-Alcoholic Fatty Liver Disease

被引：4
|
作者：
Manickam, Palaniappan [1 ]
Sudhakar, Rajeev [2 ]
机构：
[1] William Beaumont Hosp, Dept Gastroenterol, Royal Oak, MI 48072 USA
[2] Wayne State Univ, Dept Internal Med, Detroit, MI 48201 USA
来源：
DIGESTIVE DISEASES AND SCIENCES | 2013年 / 58卷 / 05期
关键词：
Valproic Acid; Zidovudine; Chronic Liver Disease; Hepatic Steatosis; Didanosine;
D O I：
10.1007/s10620-013-2577-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1435 / 1435
页数：1
相关论文
共 50 条
  • [21] Non-Alcoholic Fatty Liver Disease
    Engin, Atilla
    OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467
  • [22] Non-alcoholic fatty liver disease
    Alba, LM
    Lindor, K
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
  • [23] Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring
    Long, Michelle T.
    Gurary, Ellen B.
    Massaro, Joseph M.
    Ma, Jiantao
    Hoffmann, Udo
    Chung, Raymond T.
    Benjamin, Emelia J.
    Loomba, Rohit
    LIVER INTERNATIONAL, 2019, 39 (04) : 740 - 747
  • [24] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [25] Therapeutic potential of policosanol in the concurrent management of dyslipidemia and non-alcoholic fatty liver disease
    Mandeep K. Arora
    Sudhanshu Pandey
    Ritu Tomar
    Jagannath Sahoo
    Dinesh Kumar
    Ashok Jangra
    Future Journal of Pharmaceutical Sciences, 8
  • [26] Therapeutic potential of policosanol in the concurrent management of dyslipidemia and non-alcoholic fatty liver disease
    Arora, Mandeep K.
    Pandey, Sudhanshu
    Tomar, Ritu
    Sahoo, Jagannath
    Kumar, Dinesh
    Jangra, Ashok
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 8 (01)
  • [27] EFFICACY OF BLX 1002 IN ANIMAL MODELS OF NON-ALCOHOLIC FATTY LIVER DISEASE AND DYSLIPIDEMIA
    Narayanan, S.
    Vijayaraj, D.
    Kulkarni, N. M.
    Shetty, P.
    Jayanarayan, K.
    Vinitha, P. L.
    Navin, B. R.
    Mookkan, J.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S502 - S502
  • [28] New perspective on type 2 diabetes, dyslipidemia and non-alcoholic fatty liver disease
    Matsuzaka, Takashi
    Shimano, Hitoshi
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (03) : 532 - 534
  • [29] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [30] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS RELATED TO NON-ALCOHOLIC FATTY PANCREAS DISEASE (NAFPD)
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C.
    Bloemena, Elisabeth
    van der Peet, Donald L.
    Mulder, Chris J.
    HEPATOLOGY, 2009, 50 (04) : 788A - 788A
12345